194 related articles for article (PubMed ID: 26138584)
21. Proteoglycan SPOCK1 as a Poor Prognostic Marker Promotes Malignant Progression of Clear Cell Renal Cell Carcinoma via Triggering the Snail/Slug-MMP-2 Axis-Mediated Epithelial-to-Mesenchymal Transition.
Lin YW; Wen YC; Hsiao CH; Lai FR; Yang SF; Yang YC; Ho KH; Hsieh FK; Hsiao M; Lee WJ; Chien MH
Cells; 2023 Jan; 12(3):. PubMed ID: 36766694
[TBL] [Abstract][Full Text] [Related]
22. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
Mauri G; Jachetti E; Comuzzi B; Dugo M; Arioli I; Miotti S; Sangaletti S; Di Carlo E; Tripodo C; Colombo MP
Oncotarget; 2016 Jan; 7(4):3905-20. PubMed ID: 26700622
[TBL] [Abstract][Full Text] [Related]
23. Multiomic analysis of the function of
Han J; Rong Y; Gao X
J Int Med Res; 2021 Jun; 49(6):300060520962659. PubMed ID: 34156309
[TBL] [Abstract][Full Text] [Related]
24. SPOCK1 promotes the growth of Osteosarcoma cells through mTOR-S6K signaling pathway.
Wang Y; Wang W; Qiu E
Biomed Pharmacother; 2017 Nov; 95():564-570. PubMed ID: 28869894
[TBL] [Abstract][Full Text] [Related]
25. SPOCK1: a multi-domain proteoglycan at the crossroads of extracellular matrix remodeling and cancer development.
Ye Z; Chen J; Hu X; Yang S; Xuan Z; Lu X; Zhao Q
Am J Cancer Res; 2020; 10(10):3127-3137. PubMed ID: 33163261
[TBL] [Abstract][Full Text] [Related]
26. The small leucine rich proteoglycan fibromodulin is overexpressed in human prostate epithelial cancer cell lines in culture and human prostate cancer tissue.
Reyes N; Benedetti I; Bettin A; Rebollo J; Geliebter J
Cancer Biomark; 2016; 16(1):191-202. PubMed ID: 26600400
[TBL] [Abstract][Full Text] [Related]
27. Effects of shRNA-mediated knockdown of SPOCK1 on ovarian cancer growth and metastasis.
Zhang LQ; Wang Y; Zhang L
Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):102-9. PubMed ID: 26638890
[TBL] [Abstract][Full Text] [Related]
28. Cigarette smoke modulates PC3 prostate cancer cell migration by altering adhesion molecules and the extracellular matrix.
Yang S; Long M; Tachado SD; Seng S
Mol Med Rep; 2015 Nov; 12(5):6990-6. PubMed ID: 26351771
[TBL] [Abstract][Full Text] [Related]
29. Testican-3: a brain-specific proteoglycan member of the BM-40/SPARC/osteonectin family.
Hartmann U; Hülsmann H; Seul J; Röll S; Midani H; Breloy I; Hechler D; Müller R; Paulsson M
J Neurochem; 2013 May; 125(3):399-409. PubMed ID: 23418755
[TBL] [Abstract][Full Text] [Related]
30. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
Sørensen KD; Borre M; Ørntoft TF; Dyrskjøt L; Tørring N
Int J Cancer; 2008 Feb; 122(3):509-19. PubMed ID: 17943724
[TBL] [Abstract][Full Text] [Related]
32. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
Chi SG; deVere White RW; Muenzer JT; Gumerlock PH
Clin Cancer Res; 1997 Oct; 3(10):1889-97. PubMed ID: 9815578
[TBL] [Abstract][Full Text] [Related]
33. RNAi screen identifies essential regulators of human brain metastasis-initiating cells.
Singh M; Venugopal C; Tokar T; Brown KR; McFarlane N; Bakhshinyan D; Vijayakumar T; Manoranjan B; Mahendram S; Vora P; Qazi M; Dhillon M; Tong A; Durrer K; Murty N; Hallet R; Hassell JA; Kaplan DR; Cutz JC; Jurisica I; Moffat J; Singh SK
Acta Neuropathol; 2017 Dec; 134(6):923-940. PubMed ID: 28766011
[TBL] [Abstract][Full Text] [Related]
34. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
[TBL] [Abstract][Full Text] [Related]
35. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.
Wong SY; Crowley D; Bronson RT; Hynes RO
Clin Exp Metastasis; 2008; 25(2):109-18. PubMed ID: 18058030
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation.
Coulson-Thomas VJ; Gesteira TF; Coulson-Thomas YM; Vicente CM; Tersariol IL; Nader HB; Toma L
Exp Cell Res; 2010 Nov; 316(19):3207-26. PubMed ID: 20727350
[TBL] [Abstract][Full Text] [Related]
37. PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer.
Boyero L; Martin-Padron J; Fárez-Vidal ME; Rodriguez MI; Andrades Á; Peinado P; Arenas AM; Ritoré-Salazar F; Alvarez-Perez JC; Cuadros M; Medina PP
Cell Oncol (Dordr); 2022 Apr; 45(2):323-332. PubMed ID: 35182388
[TBL] [Abstract][Full Text] [Related]
38. Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation.
Schulz WA; Ingenwerth M; Djuidje CE; Hader C; Rahnenführer J; Engers R
BMC Cancer; 2010 Sep; 10():505. PubMed ID: 20860828
[TBL] [Abstract][Full Text] [Related]
39. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
[TBL] [Abstract][Full Text] [Related]
40. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
